Get Your Personalized Supplement StackSupplement Stack Quiz

Advantraz

Q: Is Advantra Z effective for weight loss?

Current meta-analyses indicate that p-synephrine supplementation, including Advantra Z, does not lead to significant long-term weight loss. While it may acutely increase energy expenditure, this effect is modest and does not translate to substantial weight reduction over time.

Q: Is Advantra Z safe to use?

Short-term use of Advantra Z at studied doses (up to 49 mg daily for 15 days) appears safe for healthy adults, with no significant cardiovascular effects reported. However, individuals with heart conditions or high blood pressure should avoid it.

Q: Can Advantra Z increase heart rate or blood pressure?

Some studies have noted mild, inconsistent increases in heart rate and blood pressure with Advantra Z, but these are generally not considered clinically significant at typical doses in healthy individuals. Caution is advised, especially when combined with other stimulants.

Q: Should Advantra Z be combined with caffeine?

Advantra Z is often combined with caffeine for potential synergistic effects on metabolism. However, this combination may increase the risk of cardiovascular stimulation, so it should be used with caution and under professional guidance.

Q: How quickly do the effects of Advantra Z appear?

Metabolic effects, such as increased energy expenditure, can be observed relatively quickly, often within hours of ingesting Advantra Z. Long-term benefits, particularly for weight loss, are not well-supported by current research.

Also known as: Advantra Z, Bitter orange extract, p-synephrine extract, Citrus aurantium extract, p-synephrine

Overview

Advantra Z is a branded, standardized extract of *Citrus aurantium* (bitter orange) primarily containing p-synephrine, a protoalkaloid structurally related to phenylephrine. It is commonly utilized in dietary supplements marketed for weight management, appetite suppression, increased energy expenditure, and enhanced athletic performance. While chemically similar to ephedrine, p-synephrine exhibits different receptor binding profiles, primarily acting on beta-3 adrenergic receptors with minimal activity on cardiovascular adrenergic receptors. Research on Advantra Z and p-synephrine is moderate, with multiple human clinical trials, including randomized controlled trials (RCTs) and meta-analyses. However, findings regarding its efficacy for long-term weight loss are inconclusive or show only modest, acute effects. The quality of evidence is mixed, with some well-designed studies alongside variable results concerning both efficacy and safety.

Benefits

Advantra Z primarily demonstrates an acute, modest increase in energy expenditure. Studies show that acute ingestion of 13 mg p-synephrine, especially when combined with caffeine and green tea extract, can increase resting energy expenditure by approximately 8% in mildly obese subjects without significant short-term cardiovascular effects. This effect is considered modest and acute. Some limited evidence also suggests Advantra Z may contribute to appetite suppression, though this benefit requires further confirmation. Despite these acute metabolic effects, a meta-analysis of p-synephrine-containing supplements found no statistically significant long-term weight loss or changes in body composition after prolonged use. Benefits are primarily observed in healthy adults or mildly obese individuals, with limited data for other populations. The clinical significance of the observed energy expenditure increase is modest, and long-term weight loss benefits are not supported by current evidence.

How it works

p-Synephrine, the active compound in Advantra Z, primarily exerts its effects by acting on beta-3 adrenergic receptors. These receptors are involved in processes such as lipolysis (fat breakdown) and thermogenesis (heat production), contributing to an increased metabolic rate. Unlike ephedrine, p-synephrine exhibits minimal activity on alpha-1, alpha-2, beta-1, and beta-2 adrenergic receptors, which are largely responsible for cardiovascular stimulation. This selective action allows p-synephrine to stimulate metabolic rate and fat breakdown with limited cardiovascular effects in humans. Upon oral administration, p-synephrine is absorbed and reaches measurable serum levels, demonstrating sufficient bioavailability for systemic effects without significant accumulation or cardiovascular stimulation over short-term use.

Side effects

Advantra Z is generally well tolerated at recommended doses. In healthy adults, daily doses of up to 49 mg p-synephrine for up to 15 days have shown no significant cardiovascular or adverse effects in controlled studies. Common side effects are not consistently reported in controlled trials. Uncommon side effects, observed in 1-5% of users, may include mild increases in heart rate and blood pressure, though findings are inconsistent across studies. Serious adverse events directly attributable to p-synephrine are rare (<1%) in controlled research. However, caution is advised due to potential additive cardiovascular effects when combined with other stimulants like caffeine. Advantra Z is contraindicated for individuals with pre-existing cardiovascular disease, hypertension, or known sensitivity to stimulants. Safety data are limited for special populations, including pregnant or breastfeeding women, children, and individuals with other comorbidities, and its use is not recommended in these groups.

Dosage

Acute metabolic effects of Advantra Z have been observed with as little as 13 mg of p-synephrine, particularly when combined with caffeine and green tea extract. For general use, studies commonly employ daily dosages ranging from 30 mg to 49 mg of p-synephrine. The maximum safe dose demonstrated in short-term studies (up to 15 days) is 49 mg daily; higher doses lack sufficient safety data. Advantra Z is typically administered before meals or exercise to optimize its metabolic effects. As a standardized extract, Advantra Z ensures consistent p-synephrine content. Oral administration provides sufficient bioavailability for systemic effects, and co-administration with caffeine may enhance its thermogenic properties, though this combination should be approached with caution due to potential increased cardiovascular stimulation.

FAQs

Is Advantra Z effective for weight loss?

Current meta-analyses indicate that p-synephrine supplementation, including Advantra Z, does not lead to significant long-term weight loss. While it may acutely increase energy expenditure, this effect is modest and does not translate to substantial weight reduction over time.

Is Advantra Z safe to use?

Short-term use of Advantra Z at studied doses (up to 49 mg daily for 15 days) appears safe for healthy adults, with no significant cardiovascular effects reported. However, individuals with heart conditions or high blood pressure should avoid it.

Can Advantra Z increase heart rate or blood pressure?

Some studies have noted mild, inconsistent increases in heart rate and blood pressure with Advantra Z, but these are generally not considered clinically significant at typical doses in healthy individuals. Caution is advised, especially when combined with other stimulants.

Should Advantra Z be combined with caffeine?

Advantra Z is often combined with caffeine for potential synergistic effects on metabolism. However, this combination may increase the risk of cardiovascular stimulation, so it should be used with caution and under professional guidance.

How quickly do the effects of Advantra Z appear?

Metabolic effects, such as increased energy expenditure, can be observed relatively quickly, often within hours of ingesting Advantra Z. Long-term benefits, particularly for weight loss, are not well-supported by current research.

Research Sources

https://pmc.ncbi.nlm.nih.gov/articles/PMC3444973/ – This randomized, placebo-controlled, crossover study found that a combination of 13 mg p-synephrine, caffeine, and green tea extract acutely increased resting energy expenditure by approximately 8% in mildly obese adults without significant changes in heart rate or blood pressure. The study was small and short-duration, focusing on acute effects.
https://pubmed.ncbi.nlm.nih.gov/36235672/ – This systematic review and meta-analysis of 18 randomized controlled trials concluded that p-synephrine supplementation did not result in significant long-term weight loss. It did, however, find small but statistically significant increases in systolic and diastolic blood pressure, highlighting potential cardiovascular considerations.
https://onlinelibrary.wiley.com/doi/full/10.1002/ptr.5879 – This comprehensive review of mechanistic studies and clinical trials indicates that p-synephrine primarily acts on beta-3 adrenergic receptors, explaining its thermogenic and lipolytic effects with minimal cardiovascular stimulation. The review supports its safety at studied doses, distinguishing its mechanism from more potent stimulants like ephedrine.
https://onlinelibrary.wiley.com/doi/10.1002/ptr.5956 – This double-blind, placebo-controlled crossover study involving 16 healthy adults found that daily supplementation with 49 mg of p-synephrine for 15 days resulted in no significant changes in heart rate, blood pressure, or ECG parameters, and no reported adverse effects. The study supports the short-term safety of p-synephrine at this dose.
https://www.nutraceuticalsworld.com/breaking-news/study-confirms-advantra-z-suppresses-appetite/ – This article reports on a study suggesting that Advantra Z may have appetite-suppressing effects. While the article highlights this potential benefit, it notes that the data are limited and require further confirmation through more extensive research.